Christina Lake Cannabis Corp. (the “Company” or “CLC” or “Christina Lake Cannabis”) (CSE: CLC) (OTCQB: CLCFF) (FRANKFURT: CLB), a leading producer of high quality extracts, advanced products and sun grown cannabis, announced today that it has repaid the total principal amount due of $1.690 million under its 12% Unsecured Convertible Debentures due September 13, 2023 (the "Debentures"), the payment included outstanding interest due of $827,000. The repayment of the Debentures at maturity was financed primarily with the proceeds of the non-brokered private placement announced on September 7 and September 12, 2023.

About Christina Lake Cannabis Corp.

Christina Lake Cannabis is a licensed producer of cannabis under the Cannabis Act with a standard cultivation license and corresponding processing amendment from Health Canada as well as a research and development license. Christina Lake Cannabis’ facility consists of a 32-acre property, which includes over 950,000 square feet of outdoor grow space, offices, propagation and drying rooms, research facilities, and a facility dedicated to processing and extraction. Christina Lake Cannabis also owns a 99-acre plot of land adjoining its principal site. CLC focuses its production on creating high quality extracts and distillate for its B2B client base with proprietary strains specifically developed for outdoor cultivation to enhance extraction quality.

On behalf of Christina Lake Cannabis:

“Mark Aiken”Mark Aiken, CEO

For more information about CLC, please visit: www.christinalakecannabis.comJennifer SmithInvestor Relations and Media Inquiriesinvest@clcannabis.com902-229-7265

THE CANADIAN SECURITIES EXCHANGE (“CSE”) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE, NOR HAS OR DOES THE CSE’S REGULATION SERVICES PROVIDER.

Certain information in this news release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict. Actual results might differ materially from results suggested in any forward-looking statements. Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information. CLC assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to CLC. Additional information identifying risks and uncertainties is contained in CLC filings with the Canadian securities regulators available at www.sedar.com.

Core Laboratories (NYSE:CLB)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Core Laboratories Charts.
Core Laboratories (NYSE:CLB)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Core Laboratories Charts.